---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-197961"
form_type: "8-K"
ticker: "AVD"
cik: "0000005981"
company_name: "AMERICAN VANGUARD CORP"
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:35:15.203709+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# American Vanguard Q2 EPS -$0.42; cuts FY2024 EBITDA guidance to $40-50M; EPA suspends Dacthal

## Summary
- Net sales $128.2M vs $132.8M Q2; Adj EBITDA $6.2M vs $10.7M; EPS $(0.42) vs $(0.04).
- FY2024 guidance cut: Adj EBITDA now $40-50M (prev. $60-70M); net sales down 2% to flat (prev. +6-9%).
- EPA issued emergency suspension of Dacthal; company had voluntarily paused sales in April 2024.
- New credit agreement relaxes EBITDA covenant through Q3 2025; upsizes excluded charges; increases rates at high leverage.
- Workforce reduced ~4%; seeking partner for SIMPAS; targeting 15% Adj EBITDA margins by 2026.

## SEC filing metadata
- accession: 0001193125-24-197961
- form_type: 8-K
- ticker: AVD
- cik: 0000005981
- company_name: AMERICAN VANGUARD CORP
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/5981/000119312524197961/0001193125-24-197961-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/5981/000119312524197961/d796763d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-197961
- JSON: https://secwatch.observer/filing/0001193125-24-197961.json
- Plain text: https://secwatch.observer/filing/0001193125-24-197961.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.